NM_005629.4:c.1496-5C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005629.4(SLC6A8):​c.1496-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000997 in 1,205,694 control chromosomes in the GnomAD database, including 4 homozygotes. There are 332 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 4 hom., 134 hem., cov: 23)
Exomes 𝑓: 0.00064 ( 0 hom. 198 hem. )

Consequence

SLC6A8
NM_005629.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00004396
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.414

Publications

0 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-153694528-C-T is Benign according to our data. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694528-C-T is described in CliVar as Benign. Clinvar id is 383235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00449 (499/111068) while in subpopulation AFR AF = 0.0155 (473/30490). AF 95% confidence interval is 0.0144. There are 4 homozygotes in GnomAd4. There are 134 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1496-5C>T splice_region_variant, intron_variant Intron 10 of 12 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1466-5C>T splice_region_variant, intron_variant Intron 10 of 12 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.1151-5C>T splice_region_variant, intron_variant Intron 10 of 12 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1496-5C>T splice_region_variant, intron_variant Intron 10 of 12 1 NM_005629.4 ENSP00000253122.5 P48029-1

Frequencies

GnomAD3 genomes
AF:
0.00449
AC:
499
AN:
111016
Hom.:
4
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0155
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000758
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000246
Gnomad OTH
AF:
0.00333
GnomAD2 exomes
AF:
0.00145
AC:
265
AN:
182957
AF XY:
0.000915
show subpopulations
Gnomad AFR exome
AF:
0.0165
Gnomad AMR exome
AF:
0.000985
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000184
Gnomad OTH exome
AF:
0.000884
GnomAD4 exome
AF:
0.000642
AC:
703
AN:
1094626
Hom.:
0
Cov.:
33
AF XY:
0.000549
AC XY:
198
AN XY:
360344
show subpopulations
African (AFR)
AF:
0.0154
AC:
406
AN:
26314
American (AMR)
AF:
0.000909
AC:
32
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19370
East Asian (EAS)
AF:
0.000166
AC:
5
AN:
30192
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54062
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40454
Middle Eastern (MID)
AF:
0.000488
AC:
2
AN:
4102
European-Non Finnish (NFE)
AF:
0.000261
AC:
219
AN:
838976
Other (OTH)
AF:
0.000783
AC:
36
AN:
45958
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00449
AC:
499
AN:
111068
Hom.:
4
Cov.:
23
AF XY:
0.00403
AC XY:
134
AN XY:
33282
show subpopulations
African (AFR)
AF:
0.0155
AC:
473
AN:
30490
American (AMR)
AF:
0.000757
AC:
8
AN:
10571
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3514
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2618
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6023
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.000246
AC:
13
AN:
52797
Other (OTH)
AF:
0.00329
AC:
5
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00234
Hom.:
9
Bravo
AF:
0.00499
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Aug 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Creatine transporter deficiency Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 14, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.3
DANN
Benign
0.43
PhyloP100
0.41
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000044
dbscSNV1_RF
Benign
0.046
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200695210; hg19: chrX-152959983; API